+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Completed

Phase 3
All Genders
ID01760564

Application of Miglustat in Patients With Niemann-Pick Type C

Led by National Taiwan University Hospital · Updated on 2013-01-04

5

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

To evaluate the changes in cognitive function after miglustat treatment in Niemann-Pick type C patients.

CONDITIONS

Brief Title

Application of Miglustat in Patients With Niemann-Pick Type C

Who Can Participate

All Genders

Eligibility Criteria

Inclusion Criteria:

  • Confirm diagnosis of Niemann-Pick C disease
  • Symptomatic including motor or mental symptoms

Exclusion Criteria:

  • Unknown severe diarrhea for more than 7 day
  • Allergy to miglustat

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here